I think he's referring to the continued progress of Elite's 216 product that has many competitors feeling uneasy. In fact, there are many who will be impacted by the 216 product when ALL patents are in place. Below is a disturbing example that was in the news - and shows how competition on all fronts is going to extremes to protect their place in the market.
A Senate panel has launched a probe of possible links between three drugmakers and nonprofit medical groups that advocated for increasing the use of prescription painkillers, now the target of a nationwide law enforcement crackdown.